Controlled studies with bleomycin in solid tumors and lymphomas.
作者信息
Bonadonna G, Tancini G, Bajetta E
出版信息
Prog Biochem Pharmacol. 1976;11:172-84.
PMID:63961
Abstract
摘要
相似文献
1
Controlled studies with bleomycin in solid tumors and lymphomas.
Prog Biochem Pharmacol. 1976;11:172-84.
2
Current status of American studies with bleomycin.
Prog Biochem Pharmacol. 1976;11:158-71.
3
Clinical study with bleomycin.
Cancer. 1971 Nov;28(5):1142-6. doi: 10.1002/1097-0142(1971)28:5<1142::aid-cncr2820280509>3.0.co;2-a.
4
Bleomycin, a review.
J Med. 1976;7(5):333-428.
5
Bleomycin--a new anticancer drug.
Med Lett Drugs Ther. 1973 Dec 7;15(25):102-4.
6
[Results with the cytostatic agent bleomycin in tumour therapy (author's transl)].
Wien Klin Wochenschr. 1973 Oct 19;85(42):686-92.
7
Methotrexate, bleomycin, and high-dose-cis-dichlorodiammineplatinum(II) in the treatment of advanced epidermoid carcinoma of the head and neck.
Cancer Treat Rep. 1979 Mar;63(3):489-91.
8
A clinical trial of intravenous and intracavitary bleomycin.
Cancer. 1972 May;29(5):1413-9. doi: 10.1002/1097-0142(197205)29:5<1413::aid-cncr2820290544>3.0.co;2-r.
9
Clinical trials with bleomycin in lymphomas and in solid tumors.
Eur J Cancer (1965). 1972 Apr;8(2):205-15. doi: 10.1016/0014-2964(72)90045-x.
10
Discovery of clinical effect of bleomycin and its further development.
Prog Biochem Pharmacol. 1976;11:143-57.
Zotero 插件